AIFM2 and lung carcinoma: Additionally, Nrf2 overexpression was shown to activate FSP1, further reducing lipid free radical production by lowering CoQ10 and inhibiting ferroptosis from occurring in lung cancer, mediating resistance to ferroptosis and radiation in Keap1-deficient lung cancer cells.